T80.51
Anaphylactic reaction due to administration of blood and blood products
Clinical Classification Guidelines
Medical Intelligence & Overview
Anaphylactic reaction caused by the administration of blood and blood products is a serious and potentially life-threatening allergic response. It occurs when the immune system reacts dramatically to transfused blood components, releasing chemicals that can affect multiple organ systems. Recognizing the signs and understanding how such reactions occur are critical for timely medical intervention and patient safety.
Causes & Symptoms
Clinical Causes: Previous allergic reactions to blood transfusions Sensitization to donor plasma proteins or additives Immune system overreaction to transfused blood components Administering incompatible blood types or contaminated blood products
Key Symptoms: Sudden difficulty breathing or shortness of breath Swelling of the face, lips, tongue, or throat Rapid drop in blood pressure leading to dizziness or fainting Hives, itching, or skin rash Nausea, vomiting, or abdominal cramps Rapid heartbeat or palpitations Feeling of impending doom or extreme anxiety
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves clinical assessment based on recent blood transfusion history and characteristic symptoms. Blood tests may be used to identify markers of allergic or immune reactions, and monitoring of vital signs is crucial. In some cases, allergy testing might be employed post-reaction to identify specific sensitivities, but the immediate focus is on recognizing and managing the acute event.
Treatment Protocols: Immediate treatment involves stopping the blood transfusion and administering emergency medications such as epinephrine to counteract the allergic response. Supportive care may include oxygen therapy, intravenous fluids to stabilize blood pressure, antihistamines to reduce allergic symptoms, and corticosteroids to decrease inflammation. Patients are closely monitored in a healthcare setting to prevent progression and manage any complications. Long-term management may involve allergy assessments and future transfusion planning to prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is T80.51 a billable ICD-10 code?
Yes, T80.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.51?
Clinical documentation must specify the nature of Anaphylactic reaction due to administration of blood and blood products and any associated comorbidities for accurate reporting.
Cite this Clinical Reference